This post was originally published on Medscape
You will shortly be re-directed to the publisher's website
Delays in cancer registration probably led to a major underestimation of the effectiveness of screening colonoscopy in reducing colorectal cancer risk in the controversial NordICC trial.
Medscape Medical News